MAPT and cystic fibrosis: For example, in tau pathology, Hsp90 binding promotes tau misfolding and aggregation [94], not unlike the chaperone trap state found in CF [42],[78],[79], a result consistent with the dynamic state of the disordered tau protein and its interaction with Hsp90 in disease [95].